These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
673 related articles for article (PubMed ID: 15156950)
21. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Newman EA; Cimmino VM; Sabel MS; Diehl KM; Frey KA; Chang AE; Newman LA Ann Surg Oncol; 2006 Jan; 13(1):52-7. PubMed ID: 16372155 [TBL] [Abstract][Full Text] [Related]
22. The use of frozen section and immunohistochemistry for sentinel lymph node biopsy in breast cancer. Chao C Am Surg; 2004 May; 70(5):414-9. PubMed ID: 15156949 [TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer. Ferrari A; Rovera F; Dionigi P; Limonta G; Marelli M; Besana Ciani I; Bianchi V; Vanoli C; Dionigi R Expert Rev Anticancer Ther; 2006 Oct; 6(10):1503-15. PubMed ID: 17069533 [TBL] [Abstract][Full Text] [Related]
24. The evolving role of axillary lymph node dissection in the modern era of breast cancer management. Barry JM; Weber WP; Sacchini V Surg Oncol; 2012 Jun; 21(2):143-5. PubMed ID: 21440434 [TBL] [Abstract][Full Text] [Related]
25. [The role of sentinel node biopsy in breast cancer surgery]. Stańczyk M; Dziekiewicz M; Maruszyński M; Olszewski WL Pol Merkur Lekarski; 2005 Aug; 19(110):245-8. PubMed ID: 16245445 [TBL] [Abstract][Full Text] [Related]
26. The role of micrometastatic disease in sentinel lymph node in breast cancer. Rovera F; Frattini F; Chiappa C; Piscopo C; Bianchi V; Dionigi G; Rausei S; Boni L; Dionigi R Breast J; 2010; 16 Suppl 1():S26-8. PubMed ID: 21050305 [TBL] [Abstract][Full Text] [Related]
27. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064 [TBL] [Abstract][Full Text] [Related]
28. Sentinel node biopsy in elderly breast cancer patients. Gennari R; Rotmensz N; Perego E; dos Santos G; Veronesi U Surg Oncol; 2004 Dec; 13(4):193-6. PubMed ID: 15615656 [TBL] [Abstract][Full Text] [Related]
29. Recent advances in sentinel lymph node biopsy for breast cancer. Goyal A; Mansel RE Curr Opin Oncol; 2008 Nov; 20(6):621-6. PubMed ID: 18841040 [TBL] [Abstract][Full Text] [Related]
30. Prognosis of breast cancer patients treated with sentinel node biopsy in Japan. Imoto S; Wada N; Murakami K; Hasebe T; Ochiai A; Ebihara S Jpn J Clin Oncol; 2004 Aug; 34(8):452-6. PubMed ID: 15371462 [TBL] [Abstract][Full Text] [Related]
31. Axillary management after sentinel lymph node biopsy in breast cancer patients. Rivers A; Hansen N Surg Clin North Am; 2007 Apr; 87(2):365-77, ix. PubMed ID: 17498532 [TBL] [Abstract][Full Text] [Related]
32. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151 [TBL] [Abstract][Full Text] [Related]
33. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct]. Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792 [TBL] [Abstract][Full Text] [Related]
34. Is axillary dissection necessary after positive sentinel node biopsy? Yes! Morrow M Ann Surg Oncol; 2001 Oct; 8(9 Suppl):74S-76S. PubMed ID: 11599907 [TBL] [Abstract][Full Text] [Related]
35. Pathologic examination of the sentinel lymph node: what is the best method? Treseler P Breast J; 2006; 12(5 Suppl 2):S143-51. PubMed ID: 16958994 [TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer. Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996 [TBL] [Abstract][Full Text] [Related]
37. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer. Mullenix PS; Brown TA; Meyers MO; Giles LR; Sigurdson ER; Boraas MC; Hoffman JP; Eisenberg BL; Torosian MH Am J Surg; 2005 May; 189(5):606-9; discussion 609. PubMed ID: 15862505 [TBL] [Abstract][Full Text] [Related]
38. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years. Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841 [TBL] [Abstract][Full Text] [Related]
39. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study. Bergkvist L; de Boniface J; Jönsson PE; Ingvar C; Liljegren G; Frisell J; Ann Surg; 2008 Jan; 247(1):150-6. PubMed ID: 18156935 [TBL] [Abstract][Full Text] [Related]
40. Ductal carcinoma in situ: value of sentinel lymph node biopsy. Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]